News
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...
Global pharmaceutical stocks fell on Monday after President Donald Trump vowed to cut U.S. prescription drug prices to match ...
New data shows Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss, with 65% vs 40% of patients achieving ...
Houston-based Empower Pharmacy has repeatedly been admonished by the FDA for failing to follow federal rules that ensure drug ...
Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...
Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...
Now that trade deals are getting done, here's why this out-of-favor stock-market strategy may shine.
The U.S. and China, after trade talks in Geneva, agreed to cut tariffs on each other by 115 percentage points, for at least 90 days. Treasury Secretary Scott Bessent further added that talks on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results